NVCT
Nuvectis Pharma Inc
20.10$
-0.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.1% | 99.7% | 98.7% | 99.0% | 99.2% | 99.6% | 99.1% | 99.2% | 99.6% | 99.8% | 98.9% | 99.0% | |
| 99.1% | 99.7% | 98.7% | 99.0% | 99.2% | 99.6% | 99.1% | 99.2% | 99.6% | 99.8% | 98.9% | 99.0% | |
| 25.0% | 36.4% | 28.9% | 31.5% | 36.5% | 47.8% | 30.5% | 37.5% | 32.5% | 41.9% | 44.0% | 59.4% | |
| 25.0% | 36.4% | 28.9% | 31.5% | 36.5% | 47.8% | 30.5% | 37.5% | 32.5% | 41.9% | 44.0% | 59.4% | |
| 15.7% | 14.4% | 8.9% | 10.1% | 13.1% | 13.4% | 9.9% | 18.4% | 18.1% | 19.8% | 18.5% | 23.2% | |
| 75.0% | 63.6% | 71.1% | 68.5% | 63.5% | 52.2% | 69.5% | 62.5% | 67.5% | 58.1% | 56.0% | 40.6% | |
| -213.9% | -282.7% | -296.3% | -343.4% | -387.1% | -393.6% | -260.6% | -314.4% | -259.6% | -314.4% | -416.3% | -503.9% | |
| 72.3% | 90.8% | 84.0% | 92.4% | 99.6% | 104.8% | 66.1% | 79.1% | 63.8% | 68.8% | 92.2% | 104.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.